$0.7153
-0.00490-0.68%
At close: -
$0.6703
-0.05-6.29%
After Hours: Apr 14, 6:48 PM EDT
Comments
Loading...
PAVmed Stock Guidance | NASDAQ:PAVM | Benzinga
PAVmed issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
FAQ
What is the most recent guidance for PAVmed (PAVM)?
The most recent guidance for PAVmed (PAVM) was reported on February 22, 2021 for Q4 2020. The company provided earnings per share guidance in the range of $-0.12 to $-0.12, compared to the estimated EPS of $-0.11. Additionally, PAVmed forecasted revenue between $0.00B and $0.00B for the quarter.
Browse guidance and forecast on all stocks.